APA (7th ed.) Citation

R, C., S, O., D, B., P, G., & F, G. (2010). [Treatment of the lower urinary tract symptoms secondary to benign prostatic hyperplasia by phosphodiesterase type 5 inhibitors. Review article]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 20(9), 616. https://doi.org/10.1016/j.purol.2010.07.015

Chicago Style (17th ed.) Citation

R, Caremel, Oger-Roussel S, Behr-Roussel D, Grise P, and Giuliano F. "[Treatment of the Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia by Phosphodiesterase Type 5 Inhibitors. Review Article]." Progres En Urologie : Journal De L'Association Francaise D'urologie Et De La Societe Francaise D'urologie 20, no. 9 (2010): 616. https://doi.org/10.1016/j.purol.2010.07.015.

MLA (9th ed.) Citation

R, Caremel, et al. "[Treatment of the Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia by Phosphodiesterase Type 5 Inhibitors. Review Article]." Progres En Urologie : Journal De L'Association Francaise D'urologie Et De La Societe Francaise D'urologie, vol. 20, no. 9, 2010, p. 616, https://doi.org/10.1016/j.purol.2010.07.015.